Retain more patients by keeping them informed

Paper consent forms are lengthy, complex and intimidating. This explains why, according to a recent CISCRP study, 36% of trial patient drop-outs reported the consent process as “somewhat/very difficult” to understand.*

IQVIA's eConsent can help you lower that number.

  • Increase patient understanding and satisfaction
  • Establish trust from start of the trial
  • Monitor global consent progress in real time
  • Keep patients engaged throughout the trial
  • And, most importantly, improve patient retention

Informed patients tend to stay invested in the trial throughout its duration. eConsent on IQVIA's DrugDev Spark platform can significantly raise your retention rates and improve relationships from the start.

With our extensive trial history, IQVIA has the most eConsent experience available worldwide.

Find out about the innovations that can revolutionize patient consent.

The 2013 CISCRP Perceptions & Insights Study Report on Ineligible Participants & Those Who Terminate Participation Early